INO Stock Analysis: Buy, Sell, or Hold?
INO - Inovio Pharmaceuticals, Inc.
$1.09
0.19 (21.10%)
â˛
5d:
+63.17%
30d:
-2.68%
90d:
-19.85%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When INO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: INO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: INO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: INO is currently trading at $1.09, which is considered slightly high relative to its 30-day fair value range of $0.76 to $1.17.
Technical Outlook: Technically, INO is in a downtrend. The price is approaching resistance at $1.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 21.1% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.77 (+153.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INO is in a downtrend. The price is approaching resistance at $1.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 21.1% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.77 (+153.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.76 -
$1.17
Company Quality Score
47/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Strong upward momentum (+21.1%)
- BULLISH: Trading 153.8% below Wall St target ($2.77)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.76 -
$1.17
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.64
Resistance Level
$1.10
Current Trend
Downtrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.40
Wall Street Target
$2.77
(+153.8%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 15, 2026 2:31 AM ET
Data refreshes hourly during market hours. Next update: 3:31 AM
Data refreshes hourly during market hours. Next update: 3:31 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 60 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 46 HOLD |
